Navigation Links
In Chronic Diseases - Poor compliance of Patients with drug treatment

A WHO report from Geneva has shown that Only approximately 50% of patients in developed countries are compliant and adhere to treatment in chronic diseases and this is even lower in developing countries. The compliance of patients to adhere to the long-term treatment medication of diseases such as cardiovascular diseases, HIV/AIDS, or depression, is poor.
In the findings of the WHO’s newly published report entitled "Adherence to Long-Term Therapies",it was found that in Gambia, China, and the United States only 27%, 43% and 51%, respectively, of patients //adhere to their medication regimen for high blood pressure. Similar patterns have been reported for other conditions such as depression (40%-70%), asthma (43% for acute treatments and 28% for maintenance), and HIV/AIDS (37%-83%). In the United States, the United Kingdom and in Venezuela, only 30%, 7% and 4.5%, of treated patients, respectively, had good control of blood pressure. In Sudan, only 18% of non-adherent patients achieved good blood pressure control compared to 96% of those who adhered.

"Poor adherence is the primary reason for not achieving the full health benefits medicines can provide to patients. It causes medical and psychosocial complications of disease, reduces patients’ quality of life, increases the likelihood of development of drug resistance and wastes health care resources," said Dr Derek Yach, Executive Director, Noncommunicable Diseases and Mental Health, World Health Organization.

"Taken together, these direct consequences impair the ability of health care systems around the world to achieve population health goals."

The adherence problem is set to expand as the worldwide burden of chronic diseases increases. Noncommunicable diseases (e.g. cardiovascular disease, cancer, diabetes), mental health disorders, HIV/AIDS and tuberculosis combined represented 54% of the global burden of illness in 2001 and are expected to exceed 65% in 2020.
'"/>




Page: 1 2

Related medicine news :

1. Roller coasters – cause “Chronic Headache?
2. New Treatment for Chronic Eczema
3. Novel Therapy for Chronic Problem
4. Overcoming Chronic Fatigue
5. Chronic Fatigue, Pain Linked to Sinusitis
6. Chronic Diseases said to Cause Falls in the Elderly
7. Epilepsy Drug May Relieve Chronic Headaches
8. Women Worse Affected By Chronic Cough
9. A Drug That Might Relieve Chronic Cough
10. A Sedentary Childhood Could Lead To Chronic Fatigue Latter In Life
11. Drug Resistance Questioned in Patients With Chronic Sinusitis

Post Your Comments:
(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...
(Date:11/25/2009)...reatment clinics to resume Monday, Nov. 30 , ... 2009 -- Centegra Health System is continuing to o... four Centegra Primary Care (CPC) vaccination clin... The clinics are at CPC sites in Huntley, Woodstoc...llows: ,   From 4:30 to 7:30 p.m. Tues...
(Date:11/25/2009)...mptoms, study finds , , WEDNESDAY, Nov....are among the potential problems faced by long-ter...with cisplatin-based chemotherapy, a new study has...n treated for unilateral testicular cancer between... conducted from 1998 to 2002. , The researchers...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...lity drugs to get pregnant can breathe a sigh of r...he popular medications used to increase the number...e do not increase the risk of ovarian cancer. // ...ad difficulty conceiving took fertility drugs and ...
...ated that Men who suffer from constipation are mor...in disease Parkinson's some have suggested that th...f the gut long before it manifests itself elsewher...high risk of developing the disease in the future....
...ng under polluted, hazy skies move away to communi...ore quickly, according to a study by researchers a...dicine researchers followed more than 100 children...affected annual rates of lung function growth, the...
...euths found that the absence of a certain protein ... water levels.Reported in the New England journal ...ey works.// The protein aquaporin-1has a d...ency of the protein have a limited ability to reab...
... bagged the registration, production and marketing...he Centre for Biotechnology in the Jawaharlal Nehr...e would be in the market in 3-4 months. The Compan...t to make any projections on the business the vacc...
...covered that frequent sexual intercourse can actua...attack.Middle aged men can have sex as many times/...f having a stroke, according to research. P...between sex and strokes. The team based its findin...
Other Medicine News:Health News:Particulate matter affects lung development 2
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--He... advanceddiagnosticandspecialtyproductstotheveteri...nosticsCorporationforthesupplyofbloodgasproductsan..., (Logo: http://www.newscom.com/cgi-bin/prnh/20000...ssionforinnovatinginthefieldofadvancedpoint-of-car...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearch... Stelara report,thefirstinamulti-phasesyndicatedm...ho-Biotech,sStelara,fromproductlaunchthroughthefir...desquantitativeinformationfrom75uniqueDermatologis...rtsassesstrialanduseofStelara,obstaclestouse,typic...
(Date:11/25/2009)..., BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBio...tofantithromboticaptamerswithactivecontrolagents,a...resentingatthePiperJaffray21stAnnualHealthCareConf...o,spresentationwillbegivenat1:10pm(EST)onTuesday,D...linewithemphasisontheleaddevelopmentprogram,theant...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Firm Parents Keep Teen Drivers Safe 58357 1Firm Parents Keep Teen Drivers Safe 58357 2Firm Parents Keep Teen Drivers Safe 58357 3Loyola University Chicago awarded scholarships for accelerated nursing students 58354 1Loyola University Chicago awarded scholarships for accelerated nursing students 58354 2M D Anderson scientist wins NIH New Innovator Award 58351 1M D Anderson scientist wins NIH New Innovator Award 58351 2M D Anderson scientist wins NIH New Innovator Award 58351 3
...in treating pediatric acute lymphoblastic,leukemia...ians treat,adolescents and adults with the disease... that has occurred in the cure rate for children w...ficult to replicate in older,patients without cons...cle,by St. Jude Children,s Research Hospital autho...
... NanoBio Corporation,announced today that it has ... its phase 2 study of NB-002, a topical lotion for... remain confidential, the results clearly,justify ...sts., "Allowing adequate time for subjects to gro... infection will enable us to generate data on,comp...
Other Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: